- Home
- FRSX vs ALZN Comparison
FRSX vs ALZN Comparison
Compare FRSX & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- ALZN
- Stock Information
- Founded
- FRSX N/A
- ALZN 2016
- Country
- FRSX Israel
- ALZN United States
- Employees
- FRSX N/A
- ALZN N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- FRSX Technology
- ALZN Health Care
- Exchange
- FRSX Nasdaq
- ALZN Nasdaq
- Market Cap
- FRSX 7.1M
- ALZN 7.5M
- IPO Year
- FRSX 2017
- ALZN 2021
- Fundamental
- Price
- FRSX $2.30
- ALZN $2.40
- Analyst Decision
- FRSX
- ALZN Strong Buy
- Analyst Count
- FRSX 0
- ALZN 1
- Target Price
- FRSX N/A
- ALZN $42.00
- AVG Volume (30 Days)
- FRSX 66.1K
- ALZN 138.3K
- Earning Date
- FRSX 11-28-2025
- ALZN 12-11-2025
- Dividend Yield
- FRSX N/A
- ALZN N/A
- EPS Growth
- FRSX N/A
- ALZN N/A
- EPS
- FRSX N/A
- ALZN N/A
- Revenue
- FRSX $452,000.00
- ALZN N/A
- Revenue This Year
- FRSX N/A
- ALZN N/A
- Revenue Next Year
- FRSX N/A
- ALZN N/A
- P/E Ratio
- FRSX N/A
- ALZN N/A
- Revenue Growth
- FRSX N/A
- ALZN N/A
- 52 Week Low
- FRSX $1.98
- ALZN $2.06
- 52 Week High
- FRSX $18.41
- ALZN $15.66
- Technical
- Relative Strength Index (RSI)
- FRSX 56.21
- ALZN 51.56
- Support Level
- FRSX $2.15
- ALZN $2.18
- Resistance Level
- FRSX $2.65
- ALZN $2.47
- Average True Range (ATR)
- FRSX 0.16
- ALZN 0.15
- MACD
- FRSX -0.04
- ALZN -0.00
- Stochastic Oscillator
- FRSX 38.78
- ALZN 55.40
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.